GE HealthCare Technologies (GEHC) Projected to Release Quarterly Earnings on Wednesday

GE HealthCare Technologies (NASDAQ:GEHC) will likely be announcing its Q3 2026 results before the market opens on Wednesday, October 28th. Analysts expect GE HealthCare Technologies to post earnings of $1.20 per share and revenue of $5.35 billion for the quarter. Investors can check the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Wednesday, October 28, 2026 at 8:30 AM ET.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, July 29th. The company reported $1.13 EPS for the quarter, beating analysts’ consensus estimates of $1.04 by $0.09. The firm had revenue of $5.29 billion for the quarter, compared to the consensus estimate of $5.26 billion. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The firm’s revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the firm posted $1.06 earnings per share. On average, analysts expect GE HealthCare Technologies to post $4.93 EPS for the current fiscal year and $5.41 EPS for the next fiscal year.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $71.45 on Monday. The firm has a market cap of $32.27 billion, a PE ratio of 16.39, a P/E/G ratio of 1.89 and a beta of 0.73. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.97 and a current ratio of 1.26. The firm’s 50 day moving average price is $68.26 and its two-hundred day moving average price is $66.76. GE HealthCare Technologies has a twelve month low of $58.75 and a twelve month high of $89.77.

GE HealthCare Technologies Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be paid a dividend of $0.04 per share. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.67%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on GEHC. Evercore restated an “outperform” rating and set a $84.00 price target on shares of GE HealthCare Technologies in a report on Thursday, July 30th. UBS Group increased their price objective on GE HealthCare Technologies from $67.00 to $73.00 and gave the stock a “neutral” rating in a report on Friday, July 31st. BTIG Research reduced their price objective on GE HealthCare Technologies from $79.00 to $75.00 and set a “buy” rating for the company in a research report on Monday, October 12th. Wells Fargo & Company lifted their price objective on GE HealthCare Technologies from $75.00 to $85.00 and gave the company an “overweight” rating in a research report on Thursday, July 30th. Finally, Zacks Research upgraded GE HealthCare Technologies from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $78.35.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc is a global medical technology company that develops and provides products, services and digital solutions for healthcare providers. Its offerings are designed to support the diagnosis, treatment and monitoring of patients across hospitals, outpatient facilities, imaging centers and other care settings.

The company’s portfolio includes medical imaging systems such as computed tomography, magnetic resonance imaging, molecular imaging, surgical imaging and X-ray equipment.